Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sy

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
Vaccine|January 4, 2022
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systemsHolly C Groom, Bradley Crane, Allison L Naleway, et al.
Nature Communications|May 22, 2024
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infectionDebbie E Malden, In-Lu Amy Liu, Lei Qian, et al.
Human Vaccines & Immunotherapeutics|April 4, 2024
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineagesBradley K Ackerson, Katia J Bruxvoort, Lei Qian, et al.
Journal of Clinical and Translational Science|September 22, 2025
Building a collaborative ecosystem across the IDeA-CTR networks in response to a public health emergencyA Jerrod Anzalone, Sharon Patrick, Amber Abel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2025
Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024Katherine Adams, Shikha Garg, Sara Y Tartof, et al.
Lancet Regional Health. Americas|October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysisAmanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
Nature Communications|July 4, 2026
Targeted long-read sequencing enables comprehensive analysis of the genetic and epigenetic landscape of inherited myopathiesDennis Yeow, Andre L M Reis, Igor Stevanovski, et al.
Vaccine|July 15, 2025
Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive ageEmily L Reeves, Kristin Dascomb, Stephanie A Irving, et al.
JAMA Network Open|June 17, 2026
Influenza Activity and Estimated Vaccine Effectiveness During the 2025-2026 Influenza SeasonEduardo Azziz-Baumgartner, Alicia Budd, Justin S Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2024
Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United StatesMark W Tenforde, Emily L Reeves, Zachary A Weber, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
Vaccine|January 4, 2022
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systemsHolly C Groom, Bradley Crane, Allison L Naleway, et al.
Nature Communications|May 22, 2024
Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infectionDebbie E Malden, In-Lu Amy Liu, Lei Qian, et al.
Human Vaccines & Immunotherapeutics|April 4, 2024
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineagesBradley K Ackerson, Katia J Bruxvoort, Lei Qian, et al.
Journal of Clinical and Translational Science|September 22, 2025
Building a collaborative ecosystem across the IDeA-CTR networks in response to a public health emergencyA Jerrod Anzalone, Sharon Patrick, Amber Abel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2025
Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024Katherine Adams, Shikha Garg, Sara Y Tartof, et al.
Lancet Regional Health. Americas|October 3, 2025
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023-March 2024: a test-negative design analysisAmanda B Payne, Steph Battan-Wraith, Elizabeth A K Rowley, et al.
Nature Communications|July 4, 2026
Targeted long-read sequencing enables comprehensive analysis of the genetic and epigenetic landscape of inherited myopathiesDennis Yeow, Andre L M Reis, Igor Stevanovski, et al.
Vaccine|July 15, 2025
Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive ageEmily L Reeves, Kristin Dascomb, Stephanie A Irving, et al.
JAMA Network Open|June 17, 2026
Influenza Activity and Estimated Vaccine Effectiveness During the 2025-2026 Influenza SeasonEduardo Azziz-Baumgartner, Alicia Budd, Justin S Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2024
Influenza vaccine effectiveness against hospitalizations and emergency department or urgent care encounters for children, adolescents, and adults during the 2023-2024 season, United StatesMark W Tenforde, Emily L Reeves, Zachary A Weber, et al.
Pageof 35